FDA recall record

A-S Medication Solutions LLC Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and recall — FDA D-1111-2018

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Class IIclassification
D-1111-2018official record ID
Aug 29, 2018report date

Recall record at a glance

Official recordD-1111-2018
CategoryDrug Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmA-S Medication Solutions LLC.
Report dateAug 29, 2018
Recall initiation dateJul 17, 2018
Quantity531 bottles
LocationLibertyville, IL, United States

Official product description

Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6488-0

Why the product was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution information

Nationwide USA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugMay 12, 2021

ACETAMINOPHEN recall — FDA D-0358-2021

Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label…

Class IFDA: TerminatedA-S Medication Solutions LLC.